Trade in substandard and falsified medicines

Trade in substandard and falsified medicines

According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical capacity and poor governance contribute to th...

書誌詳細
主要な著者:	Hagen, N, Hauk, C, Heide, L
その他の著者:	Brombacher, D
フォーマット:	Book section
言語:	English
出版事項:	Nomos 2022

類似資料

Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
著者:: Hauk, C, 等
出版事項: (2021)

Substandard and Falsified Medicines in Myanmar
著者:: Mirai Sakuda, 等
出版事項: (2020-03-01)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
著者:: Cavany, S, 等
出版事項: (2023)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
著者:: Sean Cavany, 等
出版事項: (2023-10-01)

How to achieve international action on falsified and substandard medicines.
著者:: Attaran, A, 等
出版事項: (2012)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
著者:: Veronika J Wirtz, 等
出版事項: (2019-07-01)

Combatting substandard and falsified medicines: a view from Rwanda.
著者:: Agnes Binagwaho, 等
出版事項: (2013-01-01)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
著者:: Robin Rojas-Cortés
出版事項: (2020-10-01)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
著者:: Elizabeth Pisani, 等
出版事項: (2021-08-01)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
著者:: Yusuf Hassan Wada, 等
出版事項: (2022-06-01)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
著者:: Faris El-Dahiyat, 等
出版事項: (2021-10-01)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
著者:: Albert Petersen, 等
出版事項: (2017-01-01)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
著者:: Paul N Newton, 等
出版事項: (2022-08-01)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
著者:: Zabala, GA, 等
出版事項: (2022)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
著者:: Tamara Akpobolokemi, 等
出版事項: (2022-01-01)

The economic impact of substandard and falsified antimalarial medications in Nigeria.
著者:: Sarah M Beargie, 等
出版事項: (2019-01-01)

The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products
著者:: Naughton, B
出版事項: (2018)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
著者:: Tabernero, P, 等
出版事項: (2022)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
著者:: Tabernero, P, 等
出版事項: (2019)

Technologies for detecting falsified and substandard drugs in low and middle-income countries.
著者:: Stephanie Kovacs, 等
出版事項: (2014-01-01)

Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab
著者:: Gesa Gnegel, 等
出版事項: (2022-07-01)

The concept of substandard (falsified and poor quality) industrial products and its types
著者:: K. A. Utarov, 等
出版事項: (2022-09-01)

The concept of substandard (falsified and poor quality) industrial products and its types
著者:: K. A. Utarov, 等
出版事項: (2022-09-01)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
著者:: Waleed M. Sweileh
出版事項: (2021-09-01)

Mobile apps for detecting falsified and substandard drugs: A systematic review.
著者:: Agustín Ciapponi, 等
出版事項: (2021-01-01)

Exploring pharmacists' perspectives about substandard and falsified medical products through interviews
著者:: A. Persson, 等
出版事項: (2024-03-01)

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review
著者:: Biset Asrade Mekonnen, 等
出版事項: (2024-12-01)

Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy.
著者:: Graham Lawson, 等
出版事項: (2018-01-01)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
著者:: Daariimaa Khurelbat, 等
出版事項: (2020-05-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review.
著者:: Addisu Afrassa Tegegne, 等
出版事項: (2024-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review
著者:: Addisu Afrassa Tegegne, 等
出版事項: (2024-01-01)

Screening for substandard and falsified medicines in Nigeria using visual inspection and GPHF-Minilab analysis: lessons learnt for future training of health workers and pharmacy personnel
著者:: Micha Lächele, 等
出版事項: (2024-12-01)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
著者:: McManus, D, 等
出版事項: (2020)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
著者:: Dominic McManus, 等
出版事項: (2020-08-01)

Unveiling the Peril of Substandard and Falsified Medicines to Public Health and Safety in Africa: Need for All-Out War to End the Menace
著者:: Nafiu Aminu, 等
出版事項: (2017-01-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
著者:: Colleen R Higgins, 等
出版事項: (2023-01-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
著者:: Colleen R. Higgins, 等
出版事項: (2023-01-01)

Small-scale dissolution test screening tool to select potentially substandard and falsified (SF) medicines requiring full pharmacopoeial analysis
著者:: Mohammad Sofiqur Rahman, 等
出版事項: (2021-06-01)

Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
著者:: Hui-Han Chen, 等
出版事項: (2021-03-01)

Substandard, Spurious, Falsely-Labelled, Falsified and Counterfeit (SSFFC) Drugs: Time to Take a Bitter Pill
著者:: Geetha Mani, 等
出版事項: (2016-10-01)